To the Editor:
I wish to thank Dr. Charbit for his comments [1] on our recent article [2] . I address his comments here.
Kang et al. [3] demonstrated that sevoflurane did not block the hERG channel current (IKr), but rather inhibited the channel that carries IKs (potassium currents). IKr, rather than IKs, inhibition causes drug-induced torsades de pointes. Therefore, sevoflurane may be safer than other volatile agents for patients at risk of ventricular dysrhythmias. Moreover, propofol inhibits L-type calcium currents (ICa), even at clinical concentrations [4] . Blockage of ICa is known to attenuate the QT interval, prolonging the effects of many drugs [3] . However, our conclusion was probably overstated because this study did not include patients at risk of ventricular dysrhythmias.
QTc interval prolongation is correlated with sevoflurane concentration [5] . The sevoflurane concentration, in our study, was high enough to prolong the QT interval, as the ETsevo reached 1.7% immediately before intubation. However, the limitation of our study was that it did not include a control group that received only sevoflurane.
